EU orders 200m vaccine doses, Oxford drug trial paused: COVID-19 Daily Bulletin

- The EU has reserved 200 million more vaccines from U.S. drug maker Pfizer.

- UK drug maker AstraZeneca has paused global trials of its Oxford University vaccine after an unexplained illness in a participant.

- Groups of more than six people will be banned from meeting socially in England from Monday after a spike in cases.

- The vice president of the European Commission, Margaritis Schinas, says the rollout of a future vaccine will be fair and well organized.

- Spain's virus tracing app, RadarCOVID, isn't accessible to visually impaired people and could be putting the blind at risk of catching the virus, campaigners warn.

- French Prime Minister Jean Castex has tested negative for COVID-19 after coming into contact with someone who had a confirmed case, but will self-isolate for the rest of the week.

- The European Tourism Manifesto wants the EU's member states to agree on detailed thresholds to implement common measures across the bloc.

- Data from the World Health Organization show that France now has a COVID-19 incidence rate of 114.8 cases per 100,000 people over the past 14 days - a 105 percent increase.

- Pubs in Ireland that don't serve food will reopen from 21 September but will be subject to local restrictions if cases continue to rise.